Hospital-based financial analysis of endovascular therapy and intravenous thrombolysis for large vessel acute ischemic strokes: The 'bottom line'

Journal of NeuroInterventional Surgery

Volumn 7, Issue 2, 2015, Pages 150-156

  Rai, Ansaar T ^a   Evans, Kim ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; ENDOVASCULAR THERAPY; FEMALE; HEALTH ECONOMICS; HOSPITAL CHARGE; HOSPITAL COST; HOSPITAL FINANCE; HUMAN; LARGE VESSEL STROKE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MEDICARE; MORTALITY; NONSURGICAL INVASIVE THERAPY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; COST; ECONOMICS; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; STROKE; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COSTS AND COST ANALYSIS; ENDOVASCULAR PROCEDURES; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84920939303     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-011085     Document Type: Article

References (19)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012;125: E2-e220.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013;127: E6-e245.
3. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368: 893-903.
4. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368: 914-23.
5. Rai AT, Carpenter JS, Raghuram K, et al. Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: Is it time to randomize? J Neurointerventional Surg2013;5: 430-4.
6. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): A prospective cohort study. Lancet Neurol 2012;11: 860-7.
7. Brinjikji W, Rabinstein AA, Cloft HJ. Hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States are substantially higher than Medicare payments. Stroke 2012;43: 1131-3.
8. Brinjikji W, Kallmes DF, Rabinstein AA, et al. Hospitalization costs for patients with acute ischemic stroke treated with endovascular embolectomy in the United States. Stroke 2011;42: 3271-3.
9. Gold MR. Standardizing cost-effectiveness analyses: The panel on cost-effectiveness in health and medicine. Acad Radiol 1998;5(Suppl 2): S351-4.
10. Chen M. Cost-effectiveness of endovascular therapy for acute ischemic stroke. Neurology 2012;79(13 Suppl 1): S16-21.
11. Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg 2009;110: 508-13.
12. Kim AS, Nguyen-Huynh M, Johnston SC. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke 2011;42: 2013-8.
13. Yip TR, Demaerschalk BM. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke 2007;38: 1952-5.
14. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50: 883-90.
15. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38: 948-54.
16. Gonzalez RG, Lev MH, Goldmacher GV, et al. Improved outcome prediction using CT angiography in addition to standard ischemic stroke assessment: Results from the STOPStroke study. PloS one 2012;7: E30352.
17. Paliwal PR, Ahmad A, Shen L, et al. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Cerebrovasc Dis 2012;33: 446-52.
18. Saqqur M, Molina CA, Salam A, et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study. Stroke 2007;38: 69-74.
19. Shobha N, Bal S, Boyko M, et al. Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA. J Neuroimaging 2014;24: 7-10.